Seelos Therapeutics Inc (SEELQ)
0.495
+0.12
(+30.26%)
USD |
OTCM |
Nov 21, 16:00
Seelos Therapeutics Enterprise Value: 10.03M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 10.03M |
| November 20, 2024 | 9.982M |
| November 19, 2024 | 9.970M |
| November 18, 2024 | 9.986M |
| November 15, 2024 | 10.05M |
| November 14, 2024 | 10.13M |
| November 13, 2024 | 10.12M |
| November 12, 2024 | 10.13M |
| November 11, 2024 | 10.13M |
| November 08, 2024 | 10.13M |
| November 07, 2024 | 10.12M |
| November 06, 2024 | 10.11M |
| November 05, 2024 | 10.12M |
| November 04, 2024 | 10.22M |
| November 01, 2024 | 10.27M |
| October 31, 2024 | 10.26M |
| October 30, 2024 | 10.30M |
| October 29, 2024 | 10.25M |
| October 28, 2024 | 10.37M |
| October 25, 2024 | 10.35M |
| October 24, 2024 | 10.33M |
| October 23, 2024 | 10.32M |
| October 22, 2024 | 10.34M |
| October 21, 2024 | 10.31M |
| October 18, 2024 | 10.26M |
| Date | Value |
|---|---|
| October 17, 2024 | 10.26M |
| October 16, 2024 | 10.33M |
| October 15, 2024 | 10.37M |
| October 14, 2024 | 10.88M |
| October 11, 2024 | 10.88M |
| October 10, 2024 | 10.89M |
| October 09, 2024 | 11.08M |
| October 08, 2024 | 11.21M |
| October 07, 2024 | 11.17M |
| October 04, 2024 | 11.30M |
| October 03, 2024 | 11.12M |
| October 02, 2024 | 11.24M |
| October 01, 2024 | 11.22M |
| September 30, 2024 | 11.45M |
| September 27, 2024 | 11.52M |
| September 26, 2024 | 12.00M |
| September 25, 2024 | 12.18M |
| September 24, 2024 | 11.90M |
| September 23, 2024 | 11.14M |
| September 20, 2024 | 11.21M |
| September 19, 2024 | 11.24M |
| September 18, 2024 | 11.20M |
| September 17, 2024 | 11.39M |
| September 16, 2024 | 11.11M |
| September 13, 2024 | 11.20M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.855M
Minimum
Apr 02 2020
464.37M
Maximum
Apr 28 2021
83.02M
Average
47.79M
Median
Enterprise Value Benchmarks
| Cassava Sciences Inc | 1.399B |
| Cara Therapeutics Inc | -25.03M |
| Citius Pharmaceuticals Inc | 12.53M |
| Moleculin Biotech Inc | -0.9096M |
| 180 Life Sciences Corp | 7.569M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.71M |
| Total Expenses (Quarterly) | 3.139M |
| EPS Diluted (Quarterly) | 1.92 |
| Earnings Yield | -96.06K% |